Skip to content

Evaluation of "Zofa" herbal syrup in cough

Evaluation of “Zofa” herbal syrup in hospitalized patients with post infection cough: A Double Blind Randomized Clinical Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210508051215N1
Enrollment
100
Registered
2021-05-18
Start date
2021-05-02
Completion date
Unknown
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post infection cough.

Interventions

Intervention 1: Intervention group: the coded syrup will be administrated each 8h 10 cc for 1 week. Intervention 2: Control group: the coded syrup will be administrated each 8h 10 cc for 1 week.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: All hospitalized patient with post-infection cough

Exclusion criteria

Exclusion criteria: Participating in another study Known case of DM 1 & 2, seizure, pulmonary disease like asthma and COPD Drug history of phenytoin, phenobarbital, gentamicin and venlafaxin Symptoms like hemoptysis which may have special diagnosis Pregnancy and lactation Drug which may cause cough like ACEI History of Rhinitis and allergy, GERD, smoking Hypersensitivity to any ingredient of herbal syrup

Design outcomes

Primary

MeasureTime frame
Cough score in visual analogue scale. Timepoint: Day 1,2,7,14. Method of measurement: visual analogue scale.;Cough score in simplified cough score. Timepoint: Day 1,2,7,14. Method of measurement: Simplified cough score.;Score in cough symptom score. Timepoint: Day 1,2,7,14. Method of measurement: Cough symptom score.

Secondary

MeasureTime frame
Data laboratory changes. Timepoint: Daily. Method of measurement: Data laboratory from blood sample.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarziyeh Heydari

Tehran University of Medical Sciences

heydarimarziyeh89@gmail.com+98 21 6119 2321

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026